Statistics and Modelling for Health Sciences
Evaluation and Modeling with the Therapeutic Effects Group
Reix Philippe
Professeur d'université - praticien hospitalier
UCBL
69677 BRON CEDEX
Tel: 33 04 72 12 94 37
Publications
Display of 1 to 30 publications on 57 in total
The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
The Lancet Respiratory Medicine . 12 ( 11 ) : 888-900
Journal article
see the publicationLumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy
Clinical Pharmacokinetics . 63 ( 3 ) : 333-342
Journal article
see the publicationA quick access to information on influenza burden and prevention in Lyon university hospital: A prospective QR code-based information campaign in 2022–2023
Vaccine . 42 ( 21 ) : 126160
Journal article
see the publicationCOBRAPed cohort: Do sensitization patterns differentiate children with severe asthma from those with a milder disease?
Pediatric Allergy and Immunology . 35 ( 3 ) : e14112
DOI: 10.1111/pai.14112
Journal article
see the publicationImpact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
Journal of Cystic Fibrosis . 23 : 815 - 822
Journal article
see the publicationEditorial: New insights into caring for pediatric patients with cystic fibrosis
Frontiers in Pediatrics . 11
Journal article
see the publicationTheratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription
European Respiratory Journal . 62 ( 4 ) : 2300110
Journal article
see the publicationClinical problems in rare interstitial lung diseases
European Respiratory Society .
Poster
see the publicationPopulation Pharmacokinetic Modeling and Dosing Simulations of Tobramycin in Pediatric Patients with Cystic Fibrosis
Antimicrobial Agents and Chemotherapy . 65 ( 10 ) : e0073721
DOI: 10.1128/AAC.00737-21
Journal article
see the publicationUsing chest CT scan and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis
European Respiratory Journal . : 2101344
Journal article
see the publicationDiffuse alveolar haemorrhage in children: an international multicentre study
European Respiratory Society (ERS) Congress .
Conference paper
see the publicationReal-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis
Journal of Cystic Fibrosis .
Journal article
see the publicationFactors Associated with Asthma Severity in Children: Data from the French COBRAPed Cohort
Journal of Allergy and Clinical Immunology: In Practice . 9 ( 5 ) : 1969-1979
Journal article
see the publicationChest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis
ERJ Open Research . 7 ( 1 ) : 00513-2020
Journal article
see the publicationReal-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis
American Journal of Respiratory and Critical Care Medicine . 201 ( 2 ) : 188-197
Journal article
see the publicationImpact of Coexistence Phenotype Between Staphylococcus aureus and Pseudomonas aeruginosa Isolates on Clinical Outcomes Among Cystic Fibrosis Patients
Frontiers in Cellular and Infection Microbiology . 10 : 105996
Journal article
see the publicationClinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function
Journal of Cystic Fibrosis .
Journal article
see the publicationDo patients with cystic fibrosis participating in clinical trials demonstrate placebo response? A meta-analysis
Journal of Cystic Fibrosis . 18 ( 4 ) : 461 - 467
Journal article
see the publicationUsefulness of bronchoalveolar lavage in a French pediatric cohort with hypersensitivity pneumonitis
Pediatric Pulmonology . 55 ( 1 ) : 136-140
DOI: 10.1002/ppul.24546
Journal article
see the publicationHealth-related quality of life in children interstitial lung disease.
European Respiratory Society (ERS) Congress .
Conference paper
see the publicationHealth‐related quality of life in infants and children with interstitial lung disease
Pediatric Pulmonology . 54 ( 6 ) : 828-836
DOI: 10.1002/ppul.24308
Journal article
see the publicationViral respiratory tract infections in young children with cystic fibrosis: a prospective full-year seasonal study
Virology Journal . 16 ( 1 ) : 111
Journal article
see the publicationDo patients with cystic fibrosis participating in clinical trials demonstrate placebo response? A meta-analysis
Journal of Cystic Fibrosis .
Journal article
see the publicationFunctional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer28th International Congress of the European-Respiratory-Society (ERS)
28th International Congress of the European-Respiratory-Society (ERS) .
Conference paper
see the publicationDown syndrome and pulmonary hemosiderosis: an under-recognized association
European Respiratory Society (ERS) Congress .
Conference paper
see the publicationPlace de l’analyse des gènes du surfactant dans la démarche diagnostique des pneumopathies interstitielles diffuses de l’enfant et l’adulte
Assises de Génétique Humaine et Médicale .
Poster
see the publicationEosinophilic granulomatosis with polyangiitis in children: Data from the French RespiRare (R) cohort
Pediatric Pulmonology . 53 ( 12 ) : 1640-1650
DOI: 10.1002/ppul.24089
Journal article
see the publicationPulmonary hemosiderosis in children with Down syndrome: a national experience
Orphanet Journal of Rare Diseases . 13 ( 1 ) : 60
Journal article
see the publicationContribution of mutations in genes of the surfactant system to idiopathic interstitial pneumonia (IIP)
ERS International Congress 2018 abstracts . : OA547
Conference paper
see the publicationFunctional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer.
uropean Respiratory Society (ERS) Congress, .
Conference paper
see the publication